$ONCY News Article - Oncolytics Biotech Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
https://marketwirenews.com/news-releases/onco...19226.html